Colorimetric lateral flow assay (CLFA) is one of a handful of diagnostic technologies that can be truly taken out of the laboratory for point-of-care testing without the need for any equipment and skilled personnel. Despite its simplicity and practicality, it remains a grand challenge to substantially enhance the detection sensitivity of CLFA without adding complexity. Such a limitation in sensitivity inhibits many critical applications such as early detection of significant cancers and severe infectious diseases. With the rapid development of materials science and nanotechnology, signal amplification techniques that hold great potential to break through the existing detection limit barrier of CLFA have been developed in recent years. This ...
Lateral flow immunoassay (LFIA) is widely used but is limited by its sensitivity. In this study, a n...
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e....
Analytical devices for point-of-care diagnoses are highly desired and would improve quality of life ...
A simple version of immunochemical-based methods is the Lateral Flow Assay (LFA). It is a dry chemis...
Lateral flow assays (LFAs) have attracted interest due to their friendly user formats, short assay t...
Lateral flow assays (LFAs) have been introduced and developed over the last half century. This techn...
Thesis (Ph.D.)--University of Washington, 2018The simple and inexpensive sandwich-immunoassay-based ...
Climate change and the expanding global population are placing huge pressure on our planet's natural...
Lateral flow assay (LFA) is one of the most prevalent commercially available techniques for point-of...
AbstractThis manuscript provides a brief overview of latest research involving the use of lateral fl...
This manuscript provides a brief overview of latest research involving the use of lateral flow assay...
Lateral flow assays (LFAs) are the best-performing and best-known point-of-care tests worldwide. Ove...
Lateral flow paper-based biosensors merge as powerful tools in point-of-care diagnostics since they ...
The majority of lateral flow assays (LFAs) use single-color optical labels to provide a qualitative ...
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e....
Lateral flow immunoassay (LFIA) is widely used but is limited by its sensitivity. In this study, a n...
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e....
Analytical devices for point-of-care diagnoses are highly desired and would improve quality of life ...
A simple version of immunochemical-based methods is the Lateral Flow Assay (LFA). It is a dry chemis...
Lateral flow assays (LFAs) have attracted interest due to their friendly user formats, short assay t...
Lateral flow assays (LFAs) have been introduced and developed over the last half century. This techn...
Thesis (Ph.D.)--University of Washington, 2018The simple and inexpensive sandwich-immunoassay-based ...
Climate change and the expanding global population are placing huge pressure on our planet's natural...
Lateral flow assay (LFA) is one of the most prevalent commercially available techniques for point-of...
AbstractThis manuscript provides a brief overview of latest research involving the use of lateral fl...
This manuscript provides a brief overview of latest research involving the use of lateral flow assay...
Lateral flow assays (LFAs) are the best-performing and best-known point-of-care tests worldwide. Ove...
Lateral flow paper-based biosensors merge as powerful tools in point-of-care diagnostics since they ...
The majority of lateral flow assays (LFAs) use single-color optical labels to provide a qualitative ...
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e....
Lateral flow immunoassay (LFIA) is widely used but is limited by its sensitivity. In this study, a n...
Lateral flow assays (LFAs) are currently the most used point-of-care sensors for both diagnostic (e....
Analytical devices for point-of-care diagnoses are highly desired and would improve quality of life ...